We’re experiencing issues with our datasets and search. We apologise for any inconvenience while we work to fix this.
AusPAR: Imfinzi
Australian Public Assessment Report
Device/Product Name
Imfinzi
Active ingredients
Durvalumab
AusPAR Date
Published
Sponsor
Submission Number
PM-2022-01573-1-4
Submission Type
Extension of indications
Decision
Approved